DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 3308--------------------------------------------------
       Immune-suppressed patients in Ontario eligible for earlier COVID
       -19 vaccine
       By: agate Date: June 3, 2021, 1:09 am
       ---------------------------------------------------------
       This applies to people with MS in Ontario taking Ocrevus,
       Rituxan (rituximab), or Kesimpta (ofatumumab):
       From CBC News (June 2, 2021)--"More Immune-Suppressed Patients
       in Ontario Eligible for Earlier COVID-19 Vaccine":
  HTML https://www.cbc.ca/news/canada/kitchener-waterloo/more-immune-suppressed-patients-in-ontario-eligible-for-earlier-second-covid-19-vaccine-1.6050229
       *****************************************************